CARL
Carlsmed, Inc. · Healthcare · Health Information Services
Last
$11.19
−$0.23 (−2.04%) 4:00 PM ET
After hours $11.08 −$0.11 (−0.96%) 5:05 PM ET
Prev close $11.42
Open $11.45
Day high $11.99
Day low $11.07
Volume 173,084
Avg vol 195,090
Mkt cap
$310.45M
P/E ratio
-5.18
FY Revenue
$56.44M
EPS
-2.16
Gross Margin
75.89%
Sector
Healthcare
AI report sections
CARL
Carlsmed, Inc.
Carlsmed combines high gross margins, double‑digit revenue growth, and a sizable cash position with material operating losses and deeply negative free cash flow. Technically, the share price is trading above key moving averages with bullish momentum signals and recent breakout patterns, yet medium‑term returns over 3–6 months remain slightly negative. Valuation multiples appear elevated relative to current loss‑making economics, while short interest is moderate and recent news flow has been predominantly positive around product expansion and index inclusion.
AI summarized at 3:58 PM ET, 2026-05-19
AI summary scores
INTRADAY: 63 SWING: 58 LONG: 41
Volume vs average
Intraday (cumulative)
−36% (Below avg)
Vol/Avg: 0.64×
RSI
56.35 (Neutral)
Neutral (40–60)
MACD momentum
Intraday
+0.01 (Strong)
MACD: -0.04 Signal: -0.05
Short-Term
+0.11 (Strong)
MACD: 0.49 Signal: 0.37
Long-Term
+0.20 (Strong)
MACD: 0.27 Signal: 0.07
Intraday trend score 27.22

Latest news

CARL 3 articles Positive: 3 Neutral: 0 Negative: 0
Positive GlobeNewswire Inc. • Carlsmed, Inc.
Carlsmed Announces U.S. Launch of its aprevo® Technology Platform for Cervical Fusion Surgeries at the Cervical Spine Research Society (CSRS) 53rd Annual Meeting

Carlsmed launched its aprevo® Technology Platform for cervical fusion surgeries, featuring AI-driven preoperative planning and 3D-printed patient-specific implants. The platform aims to improve surgical outcomes and precision in spine procedures.

CARL spine surgery AI personalized medicine medical technology cervical fusion
Sentiment note

Company launched innovative medical technology platform, completed first 50+ clinical cases, received positive clinical feedback, and demonstrated potential to transform spine surgery standard of care

Positive GlobeNewswire Inc. • Mike Cordonnier
Carlsmed, Inc. Appoints Jennifer Kamocsay as Chief Legal Officer and Secretary

Carlsmed has appointed Jenifer Kamocsay as Chief Legal Officer and Secretary, bringing over two decades of corporate legal experience from life science and technology sectors to strengthen the company's leadership team.

CARL PRGS legal appointment corporate governance spine surgery AI technology
Sentiment note

Company is expanding leadership, strengthening organizational capabilities, and preparing for commercial launch with an experienced legal professional

Positive GlobeNewswire Inc. • Mike Cordonnier
Carlsmed, Inc. Selected for Inclusion in Russell 2000® Index

Carlsmed, a medical technology company specializing in AI-enabled personalized spine surgery solutions, was added to the Russell 2000 Index following its IPO in July 2025.

CARL AI spine surgery medical technology Russell 2000 Index IPO
Sentiment note

Company achieved significant milestone by being added to Russell 2000 Index, indicating growth potential and market recognition

News and sentiment labels describe article tone and are provided for research purposes only. They are not trading recommendations or forecasts.
Trade Ranks, LLC is not a registered investment adviser or broker-dealer. All rankings and AI reports are for informational and educational purposes only and are not personalized advice. Investing involves risk. Policy Portal